Vanda Pharmaceuticals (NASDAQ:VNDA)

Vanda Pharmaceuticals (NASDAQ:VNDA)


Share Price
$ 17.31
Change
0.52 (3.10 %)
Market Cap
$911.25 m
Proactive Investors - Run By Investors For Investors

Vanda Pharmaceuticals

Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. Its product portfolio includes Fanapt, a compound for the treatment of schizophrenia, and Tasimelteon is a compound for the treatment of sleep and mood disorders.

EPIC: VNDA
Market: NASDAQ:VNDA
52-week High/Low: $33.39 / $13.90
Sector: Pharmaceuticals
Market Cap: $911.25 m
Website: www.vandapharma.com
col 3
col 4
col 5
col 6

Vanda Pharmaceuticals Timeline

Market Reports Including VNDA

VIEW ALL
Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use